In addition, B. fragilis elicited Th1 immune responses and favored the maturation of intratumoral DCs, which potentiated the therapeutic efficacy of cytotoxic T lymphocyte-associated protein 4 (CTLA-4) blockade in fibrosarcoma-bearing mice (67). The gene discussed is CTLA4; the disease is fibrosarcoma.